Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Use of NPSP558 in the Treatment of Hypoparathyroidism (REPLACE)

This study has been completed.
Information provided by (Responsible Party):
NPS Pharma Identifier:
First received: August 8, 2008
Last updated: October 11, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2011
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: October 9, 2012